Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

ViiV Healthcare launches dolutegravir in Japan

April 17, 2014

Bristol-Myers Squibb files NDA for HIV-1 fixed-dose combination tablet

April 15, 2014

ViiV Healthcare and MPP to improve access to dolutegravir

April 7, 2014

Janssen submits NDA to the FDA for darunavir/cobicistat fixed-dose combination tablet

April 2, 2014

Tivicay obtains approval in Japan for HIV

March 25, 2014

Chinese group presents novel agents for HIV and HBV infection

March 20, 2014

Peptide triazole KR-13 induces cell-free HIV-1 virolysis

March 19, 2014

Novel HIV-1 maturation inhibitor candidates with improved profile

March 19, 2014

GSK-744/rilpivirine as maintenance therapy for HIV infection

March 14, 2014

Potent antiviral activity and favorable safety of doravirine in HIV-1-infected patients

March 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...